Brown Advisory Inc. Has $131.03 Million Position in Encompass Health Corporation $EHC

Brown Advisory Inc. decreased its stake in Encompass Health Corporation (NYSE:EHC) by 20.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,068,491 shares of the company’s stock after selling 272,229 shares during the period. Brown Advisory Inc.’s holdings in Encompass Health were worth $131,029,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. WPG Advisers LLC acquired a new stake in Encompass Health during the 1st quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Encompass Health by 749.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after purchasing an additional 367 shares during the period. Employees Retirement System of Texas bought a new stake in shares of Encompass Health in the 2nd quarter valued at $57,000. Parkside Financial Bank & Trust increased its position in shares of Encompass Health by 179.5% during the second quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after buying an additional 307 shares during the period. Finally, Park Place Capital Corp bought a new position in Encompass Health during the second quarter worth $72,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Trading Up 0.0%

Shares of Encompass Health stock opened at $113.05 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.99. The stock has a 50 day moving average price of $119.47 and a two-hundred day moving average price of $119.34. The stock has a market capitalization of $11.38 billion, a PE ratio of 21.37, a price-to-earnings-growth ratio of 1.99 and a beta of 0.73.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, equities analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a $0.19 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. KeyCorp increased their price target on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. UBS Group lifted their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Barclays increased their price target on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. Finally, Truist Financial lifted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $142.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.